BBRRF Stock Chart & Stats
$0.01
<$0.01(42.96%)
At close: 4:00 PM EDT
$0.01
<$0.01(42.96%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume10.00K
Average Volume (3M)101.49K
Market Cap
$3.54M
Enterprise Value$4.94M
Total Cash (Recent Filing)$14.77K
Total Debt (Recent Filing)$8.28K
Price to Earnings (P/E)―
Beta-0.04
Next Earnings
Nov 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding495,090,100
10 Day Avg. Volume54,367
30 Day Avg. Volume101,491
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)14.73
Price to Sales (P/S)15.15
P/FCF Ratio-3.80
Enterprise Value/Market Cap1.40
Enterprise Value/Revenue17.77
Enterprise Value/Gross Profit48.38
Enterprise Value/Ebitda-7.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.04
Revenue Forecast (FY)$37.85M
Bulls Say, Bears Say
Bulls Say
Gross Margin ImprovementThe substantial gross-margin improvement indicates better economics on the company’s reported revenue base and provides a stronger foundation for future operating leverage. However, this benefit remains incomplete because operating costs still materially exceed revenue and the business remains loss-making.
Lower LeverageThe reduced debt-to-equity ratio lowers direct leverage pressure and may provide more balance-sheet flexibility than in earlier periods. Lower absolute debt can reduce financing strain, although sharply reduced equity means the company’s overall financial resilience remains limited.
Reduced Cash BurnA roughly halved cash burn suggests some operational improvement and could extend the company’s ability to fund activity before additional capital is required. The improvement is not yet self-sustaining, because operations continue to consume cash rather than generate it.
Bears Say
Revenue DeclineDeclining trailing revenue points to weakening commercial scale and makes it harder to absorb the company’s existing cost base. Without renewed top-line growth, the improved gross margin may not translate into meaningful operating progress or a credible path toward breakeven.
Deep Operating LossesExtremely negative operating and net margins show that expenses remain far above the current revenue base, making profitability highly dependent on major cost reductions or substantial growth. Persistent losses can continue eroding equity and limit the company’s strategic flexibility.
Negative Cash GenerationOngoing negative operating and free cash flow means the business is not currently funding operations internally and remains reliant on external capital. Continued cash consumption can weaken financial resilience, constrain investment capacity, and increase funding pressure if losses persist.
Blueberries Medical News
BBRRF FAQ
What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Blueberries Medical Corp’s market cap?
Blueberries Medical Corp’s market cap is $3.54M.
When is Blueberries Medical Corp’s upcoming earnings report date?
Blueberries Medical Corp’s upcoming earnings report date is Nov 30, 2026 which is in 36 days.
How were Blueberries Medical Corp’s earnings last quarter?
Blueberries Medical Corp released its earnings results on Aug 31, 2026. The company reported $0 earnings per share for the quarter.
Is Blueberries Medical Corp overvalued?
According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued.
Does Blueberries Medical Corp pay dividends?
Blueberries Medical Corp does not currently pay dividends.
What is Blueberries Medical Corp’s EPS estimate?
Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blueberries Medical Corp have?
Blueberries Medical Corp has 495,090,100 shares outstanding.
What happened to Blueberries Medical Corp’s price movement after its last earnings report?
Blueberries Medical Corp reported an EPS of $0 in its last earnings report. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Blueberries Medical Corp?
Currently, no hedge funds are holding shares in BBRRF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blueberries Medical Corp
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and its associated products across Colombia. Their offerings notably include medicinal cannabis oil extracts and other complementary items.
Technical Analysis
Ownership Overview
78.60% Insiders
<0.01% Other Institutional Investors
21.39% Public Companies and
Individual Investors